Novel Iridium Complex for Asymmetric Hydrogenation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing iridium complexes used in asymmetric hydrogenation reactions often fail to achieve sufficient catalytic activities and enantiomeric excesses for certain substrates, despite the use of various additives.
Innovation Solution
Development of a novel iridium complex represented by the general formula IrHZ2(PP)(Q)m, where Z is a halogen atom, PP is an optically active bisphosphine, and Q is an amine, which enhances enantioselectivity and catalytic activity in asymmetric synthesis reactions, particularly in asymmetric hydrogenation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If various additives (iodine, tetrabutylammonium bromide, bismuth iodide, etc.) are added to iridium complexes, then catalytic activity and enantiomeric excess are improved, but for some substrates sufficient catalytic activities and enantiomeric excesses still cannot be achieved
Solution Approach 1:
The patent changes the chemical parameters of the iridium complex by introducing a specific coordination structure with amine and phosphine ligands, transforming the catalyst's properties to achieve both high activity and broad substrate applicability. This resolves the contradiction by modifying the catalyst's inherent parameters rather than relying on additives that work only for specific substrates.
Solution Approach 2:
The patent creates a composite catalyst system where iridium is coordinated with both amine (Q) and phosphine (PP) ligands in a specific geometry. This composite structure combines the advantages of different ligand types, enabling the catalyst to maintain high enantiomeric excess while achieving broad substrate versatility that single-ligand systems or additives cannot provide.
2Manufacturing precision
If conventional iridium complexes are used for asymmetric hydrogenation, then certain substrates can be processed, but sufficient enantiomeric excess and catalytic activity cannot be achieved
Solution Approach 1:
The patent modifies key parameters of the iridium complex including oxidation state (IrIII), coordination geometry (square planar), and ligand types (amine + phosphine combination). These parameter changes simultaneously enhance both enantiomeric excess (precision) and catalytic activity (productivity) by creating a more effective catalytic cycle.
Solution Approach 2:
The patent introduces local chirality through the amine ligand Q with specific stereochemistry, which creates a chiral environment at the catalytic center. This local chiral structure is responsible for high enantiomeric excess, while the overall complex structure maintains high catalytic activity, resolving the contradiction between precision and productivity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The novel iridium complex achieves high yields and stereoselectivity in asymmetric hydrogenation reactions, producing optically active compounds with improved enantiomeric excesses, making them suitable for various synthetic intermediates.
Implementation Method 1
Complexes containing rhodium, ruthenium, or iridium are mainly used as catalysts for asymmetric hydrogenation reactions
Implementation Method 2
Synthetic methods based on catalytic asymmetric hydrogenation reactions are still being actively investigated as methods for synthesizing optically active compounds
Data Source
AI summary
An object of the present invention is to provide a novel iridium complex, and to provide a novel catalyst having excellent performances in terms of enantioselectivity, catalytic activity, and the like. Provided is an iridium complex of the following general formula (1): IrHZ2(PP)(Q)m (1) wherein Z represents a halogen atom, PP represents a bisphosphine, Q represents an amine, and m represents 1 or 2.